ustekinumab,vedolizumab,ozanimod,upadacitinib
janssen,takeda,bms,abbvie
['vedolizumab', 'crohn', ' vedo', 'ustekinumab', 'ibd']
the increasing number of tx opportunities in #ibd the increasing number of questions many answers regarding: efficacy positioning safety during #aibd2022 
MD, Professor, gastroenterologist at Pozna? University of Medical Sciences. 
myUEG Associate.
Special interest: #IBD, #immunology, #GIEndoscopy, #LiverDiseases